Registration statement for securities of certain foreign private issuers

Capital and Reserves - Additional Information (Detail)

v3.21.2
Capital and Reserves - Additional Information (Detail)
$ / shares in Units, $ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
Director
shares
Dec. 16, 2020
USD ($)
Dec. 02, 2020
USD ($)
Nov. 16, 2020
USD ($)
Nov. 12, 2020
USD ($)
$ / shares
Jun. 30, 2021
USD ($)
Director
shares
Dec. 31, 2020
USD ($)
Director
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Disclosure of classes of share capital [line items]                
Conversion of convertible debt amount           $ 70,000 $ 30,189  
Proceeds from notes issued             $ 100,000 $ 51,064
Preference C Shares [member]                
Disclosure of classes of share capital [line items]                
Increase decrease in the number of shares issued | shares             24,796,225 227,380,145
Sale of stock issue price per share | $ / shares             $ 0.00001277 $ 0.00001277
Issue of equity             $ 42,097 $ 337,271
Ordinary shares [member] | Ordinary A Shares [member]                
Disclosure of classes of share capital [line items]                
Voting rights percentage 50.00%         50.00% 50.00%  
Number of additional directors entitled to be appointed by the majority shareholders | Director 1         1 1  
Ordinary shares [member] | Ordinary B Shares [member]                
Disclosure of classes of share capital [line items]                
Increase decrease in the number of shares issued | shares           17,206,000    
Voting rights percentage 50.00%         50.00% 50.00%  
Number of directors entitled to be appointed by the qualifying stakeholder | Director 1         1 1  
Preference shares [member] | Preference C Shares [member]                
Disclosure of classes of share capital [line items]                
Increase decrease in the number of shares issued | shares           41,012,000 24,796,000  
Voting rights percentage 50.00%         50.00% 50.00%  
Number of directors entitled to be appointed by the largest shareholder | Director 1         1 1  
Number of directors entitled to be appointed by the qualifying stakeholder | Director 1         1 1  
Cash Received [member] | Preference C Shares [member]                
Disclosure of classes of share capital [line items]                
Increase decrease in the number of shares issued | shares             6,976,194  
Proceeds from issue of preference shares             $ 11,908  
Tranche One [member] | Global Health Equity (Cyprus Limited) [member] | Convertible Loan Agreement [member]                
Disclosure of classes of share capital [line items]                
Notes and debentures issued         $ 30,000      
Proceeds from notes issued         $ 30,000      
Borrowings interest rate         11.00%      
Convertible debt conversion price per share | $ / shares         $ 1.706802577      
Tranche One [member] | Global Health Equity (Cyprus Limited) [member] | Convertible Loan Agreement [member] | Component One [member]                
Disclosure of classes of share capital [line items]                
Proceeds from notes issued       $ 15,000        
Tranche One [member] | Global Health Equity (Cyprus Limited) [member] | Convertible Loan Agreement [member] | Component Two [member]                
Disclosure of classes of share capital [line items]                
Proceeds from notes issued     $ 15,000          
Tranche Two [member] | Global Health Equity (Cyprus Limited) [member] | Convertible Loan Agreement [member]                
Disclosure of classes of share capital [line items]                
Notes and debentures issued         $ 70,000      
Proceeds from notes issued   $ 70,000     $ 30,000      
Borrowings interest rate         11.00%      
Tranche Two [member] | Global Health Equity (Cyprus Limited) [member] | Convertible Loan Agreement [member] | Preference C Shares [member]                
Disclosure of classes of share capital [line items]                
Conversion of convertible debt amount $ 70,000         $ 70,000    
Increase decrease in the number of shares issued | shares 41,012,358         41,012,358    
Principal [member] | Tranche Two [member] | Global Health Equity (Cyprus Limited) [member] | Convertible Loan Agreement [member] | Preference C Shares [member]                
Disclosure of classes of share capital [line items]                
Conversion of convertible debt amount             $ 30,000  
Increase decrease in the number of shares issued | shares             17,708,792  
Interest [member] | Tranche Two [member] | Global Health Equity (Cyprus Limited) [member] | Convertible Loan Agreement [member] | Preference C Shares [member]                
Disclosure of classes of share capital [line items]                
Conversion of convertible debt amount             $ 189  
Increase decrease in the number of shares issued | shares             111,239